Simple Summary Giant cell tumor of bone (GCTB) is an aggressive non-cancerous bone
tumor. Surgery remains the main treatment for GCTB. Denosumab has been approved for …

The osteochondral defects (OCDs) resulting from the treatment of giant cell tumors of bone
(GCTB) often present two challenges for clinicians: tumor residue leading to local recurrence …

Tumorigenesis exemplifies the complex process of neoplasm origination, which is
characterised by somatic genetic alterations and abnormal cellular growth. This …

Giant Cell Tumor (Osteoclastoma) Shayan Hosseinzadeh; Vivek Tiwari; Orlando De Jesus.
Author Information Last Update: January 31, 2024. Continuing Education Activity Giant cell …

Introduction Giant cell tumor of bone (GCTB) is a very rare tumor encountered in the jaws
and its histology is quite similar to the more common giant cell granuloma of the jaws …

Giant cell tumor of bone is a highly invasive benign tumor with a high postoperative
recurrence rate. Objective: This study aims to analyze the research hotspots and trends of …

Introduction Giant cell tumors of the bone (GCTB) are aggressive neoplasms, with rare
occurrences in the posterior pelvis and sacral area. Surgical challenges in this region …

Rationale and objectives Denosumab is a monoclonal antibody used neo-adjuvantly in
giant cell tumor of bone (GCTB) to facilitate surgery, or long term for axial tumors where …

Purpose This technical note describes a reconstructive technique of the distal tibial articular
surface using autologous iliac crest bone graft. Methods Following curettage and high …

Objective Recurrent giant cell tumor (RGCT) of the spine represents a clinical challenge for
surgeons, and the treatment strategy remains controversial. This study aims to describe the …